Efficacy of Ultrasound-Guided Glenohumeral Joint Injections of Leukocyte-Poor Platelet-Rich Plasma Versus Hyaluronic Acid in the Treatment of Glenohumeral Osteoarthritis: A Randomized, Double-Blind Controlled Trial
In brief
Researchers ran a double-blind randomised controlled trial of a single ultrasound-guided shoulder joint injection of leukocyte-poor platelet-rich plasma (PRP) versus hyaluronic acid for glenohumeral (shoulder) osteoarthritis. Over a year, patients in both groups improved in pain and function, but the authors found no meaningful difference between the two treatments.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Efficacy of Ultrasound-Guided Glenohumeral Joint Injections of Leukocyte-Poor Platelet-Rich Plasma Versus Hyaluronic Acid in the Treatment of Glenohumeral Osteoarthritis: A Randomized, Double-Blind Controlled Trial Authors: Jonathan S Kirschner, Jennifer Cheng, Andrew Creighton, Kristen Santiago, Nicole Hurwitz, Mark Dundas, Nicholas Beatty, Dallas Kingsbury, Gabrielle Konin, Zafir Abutalib, Richard Chang Link: https://pubmed.ncbi.nlm.nih.gov/35316820/ Year of Publication: 2022
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

